MXPA02011883A - Un estuche de combinacion usado en el tratameinto de paludismo que contiene cloroquina y 3-(1-((4 -((6-metoxi-8 -quinolinil)amino) pentil) amino) -etilideno) -dihidro-2(3h) furanona. - Google Patents

Un estuche de combinacion usado en el tratameinto de paludismo que contiene cloroquina y 3-(1-((4 -((6-metoxi-8 -quinolinil)amino) pentil) amino) -etilideno) -dihidro-2(3h) furanona.

Info

Publication number
MXPA02011883A
MXPA02011883A MXPA02011883A MXPA02011883A MXPA02011883A MX PA02011883 A MXPA02011883 A MX PA02011883A MX PA02011883 A MXPA02011883 A MX PA02011883A MX PA02011883 A MXPA02011883 A MX PA02011883A MX PA02011883 A MXPA02011883 A MX PA02011883A
Authority
MX
Mexico
Prior art keywords
treatment
amino
combination kit
days
malaria
Prior art date
Application number
MXPA02011883A
Other languages
English (en)
Inventor
Francis Joseph Pinto
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Publication of MXPA02011883A publication Critical patent/MXPA02011883A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Un estuche de combinacion para el tratamiento del paludismo producido por Plasmodium vivax (P. vivax), que tiene dosis individuales de un agente antipaludico, 3-[1-[[4- [(6-metoxi -8-quinolinil) amino]pentil] amino] etilidenol-dihidro -2(3H) furanona (I) en forma de capsulas; dosis individuales del agente antipaludico, cloroquina en forma de comprimidos; y material de instruccion para la administracion de los dos farmacos antipaludicos. El estuche de combinacion es particularmente adecuado para un regimen de tratamiento de 6 dias, en el que el tratamiento se consigue mediante cinco comprimidos que contienen 500 mg de fosfato de cloroquina (equivalentes a 300 mg de base), debiendo tomarse tres el dia uno y uno cada uno de los dias dos y tres; y cinco capsulas que contienen 25 mg de 3-[1-[[4 -[(6-metoxi- 8-quinolinil) amino ]pentil] amino ]etilideno ]-dihidro -2(3H) -furanona (I), debiendo tomarse una cada uno de los dias dos a seis.
MXPA02011883A 2000-05-31 2000-08-30 Un estuche de combinacion usado en el tratameinto de paludismo que contiene cloroquina y 3-(1-((4 -((6-metoxi-8 -quinolinil)amino) pentil) amino) -etilideno) -dihidro-2(3h) furanona. MXPA02011883A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31
PCT/IN2000/000081 WO2001091535A2 (en) 2000-05-31 2000-08-30 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält

Publications (1)

Publication Number Publication Date
MXPA02011883A true MXPA02011883A (es) 2004-05-17

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011883A MXPA02011883A (es) 2000-05-31 2000-08-30 Un estuche de combinacion usado en el tratameinto de paludismo que contiene cloroquina y 3-(1-((4 -((6-metoxi-8 -quinolinil)amino) pentil) amino) -etilideno) -dihidro-2(3h) furanona.

Country Status (28)

Country Link
US (1) US7404962B1 (es)
EP (1) EP1292306B1 (es)
JP (1) JP2004505017A (es)
KR (1) KR20030025926A (es)
AP (1) AP1435A (es)
AR (1) AR028458A1 (es)
AT (1) ATE314848T1 (es)
AU (2) AU2001228790B2 (es)
BR (1) BR0005247A (es)
CA (1) CA2413775C (es)
CR (1) CR6835A (es)
CZ (1) CZ296875B6 (es)
DE (2) DE00993875T1 (es)
DK (1) DK1292306T3 (es)
EC (1) ECSP003694A (es)
ES (1) ES2200729T3 (es)
GT (1) GT200000187A (es)
HK (1) HK1052467B (es)
HN (1) HN2001000118A (es)
HU (1) HUP0301925A3 (es)
MX (1) MXPA02011883A (es)
NO (1) NO324774B1 (es)
OA (1) OA12276A (es)
PE (1) PE20011319A1 (es)
PL (1) PL200748B1 (es)
SV (1) SV2002000201A (es)
WO (1) WO2001091535A2 (es)
ZA (1) ZA200209726B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114892B2 (en) * 2006-02-16 2012-02-14 The Mclean Hospital Corporation Methods and compositions for the treatment of Parkinson's Disease
WO2010065932A1 (en) * 2008-12-05 2010-06-10 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
JP3560970B2 (ja) * 1992-02-07 2004-09-02 ノバルティス アクチェンゲゼルシャフト ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物

Also Published As

Publication number Publication date
AU2879001A (en) 2001-12-11
WO2001091535A3 (en) 2002-07-04
HN2001000118A (es) 2001-10-29
AU2001228790B2 (en) 2007-02-01
AP2002002672A0 (en) 2002-12-31
PE20011319A1 (es) 2002-03-02
HUP0301925A3 (en) 2009-03-30
ES2200729T1 (es) 2004-03-16
HK1052467A1 (en) 2003-09-19
JP2004505017A (ja) 2004-02-19
HUP0301925A2 (hu) 2003-09-29
DE60025403D1 (de) 2006-03-30
DK1292306T3 (da) 2006-05-22
NO324774B1 (no) 2007-12-10
NO20025765D0 (no) 2002-11-29
WO2001091535B1 (en) 2002-10-31
DE00993875T1 (de) 2004-04-15
AR028458A1 (es) 2003-05-07
AP1435A (en) 2005-06-21
PL200748B1 (pl) 2009-02-27
EP1292306B1 (en) 2006-01-04
ES2200729T3 (es) 2006-07-16
ZA200209726B (en) 2004-03-10
HK1052467B (zh) 2006-03-10
CA2413775C (en) 2009-08-25
GT200000187A (es) 2002-04-18
DE60025403T2 (de) 2006-08-24
SV2002000201A (es) 2002-10-24
NO20025765L (no) 2003-01-08
PL372718A1 (en) 2005-07-25
BR0005247A (pt) 2002-02-13
WO2001091535A2 (en) 2001-12-06
CZ20024071A3 (cs) 2003-04-16
CR6835A (es) 2007-04-26
OA12276A (en) 2006-05-10
KR20030025926A (ko) 2003-03-29
US7404962B1 (en) 2008-07-29
ATE314848T1 (de) 2006-02-15
EP1292306A2 (en) 2003-03-19
ECSP003694A (es) 2002-01-25
CA2413775A1 (en) 2001-12-06
CZ296875B6 (cs) 2006-07-12

Similar Documents

Publication Publication Date Title
US6323188B1 (en) Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
DE69940674D1 (de) Orale verabreichung von adenosin analogen
FI94094B (fi) Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle
MY126555A (en) Oral pharmaceutical extended release dosage form
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
ATE292453T1 (de) Antivirale arznei
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
MX9800407A (es) Nuevos derivados de galantamina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contiene.
MXPA02011883A (es) Un estuche de combinacion usado en el tratameinto de paludismo que contiene cloroquina y 3-(1-((4 -((6-metoxi-8 -quinolinil)amino) pentil) amino) -etilideno) -dihidro-2(3h) furanona.
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
TNSN02095A1 (en) A combination kit used in the treatment of malaria
TNSN05334A1 (en) A combination kit in the treatment of malaria
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
DK1476160T3 (da) Farmaceutisk sammensætning af artesunat og mefloquin til behandling af malaria
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
RU2003112502A (ru) Адаптогенный лекарственный препарат для перорального применения
JP2004505017A5 (es)
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
RU2005101874A (ru) Синергетическое взаимодействие абакавира и аловудина
BR0008241A (pt) Utilização de fanquinona para a preparação deuma composição farmacêutica para o tratamentode enfraquecimento de memória e método detratamento
TH864C3 (th) สูตรยารักษาโรคติดยาเสพติด
TH864A3 (th) สูตรยารักษาโรคติดยาเสพติด
RU99112967A (ru) Способ лечения и профилактики дизентерии свиней
NO912497L (no) Doseringsform for administrering av kalsiumantagonist.

Legal Events

Date Code Title Description
FG Grant or registration